Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > HC Wainwright & Co

<< Previous

Bullboard Posts

Next >>

Comment by Normandton May 14, 2024 6:17pm

106 Views

Post# 36039846

RE:RE:RE:RE:RE:RE:RE:RE:HC Wainwright & Co

And regarding HC Wainwright & Co, it's strange that all the bashers said in concert, that these predictions should not be trusted, that these analysts are not reliable, that they never ask the real questions and blah blah blah. And now that one of them is revising the target price downwards...ah now it's becoming very important and it's a now a reference.

<< Previous

Bullboard Posts

Next >>

Apolo IV Acquisition and Marviken Ontario sign merger agreement